MENLO PARK, Calif.,
Nov. 28, 2021 /PRNewswire/
-- Subtle Medical, a leading healthcare technology company,
and Bayer, a leading life science company with extensive expertise
from diagnosis to care, announced today a collaboration to explore
opportunities to utilize AI (artificial intelligence) to aid in
image acquisition in radiology. The companies will investigate the
potential of Subtle Medical's state-of-the-art AI algorithm,
SubtleGAD™, for use in contrast-enhanced MRI exams to enhance image
quality and will explore potential new areas for contrast media
use.
Subtle Medical's AI technologies acquire and improve high quality
images from both accelerated and low dose scans.
"At Bayer, we are constantly striving to advance medical
knowledge and provide the best possible therapeutic and diagnostic
options for physicians and patients," said Prof. Dr. Olaf Weber, Head of Radiology Research and
Development at Bayer. "We are pleased to collaborate with Subtle
Medical to harness the power of AI, with the ultimate goal of
providing physicians with the means for optimal diagnosis for their
patients."
MRI exams enable physicians to obtain detailed images of the
body and help them answer critical medical questions in the
diagnosis and monitoring of disease. In light of an aging
population, the need for medical imaging to facilitate diagnosis,
treatment decisions and therapy planning has grown. Artificial
intelligence is a promising tool to support radiologists in their
task to provide accurate and timely diagnosis to their patients, in
addition to offering opportunities to speed up imaging exam times
and reduce dose. In particular, Subtle Medical's suite of deep
learning technologies aid in higher quality image acquisition from
both accelerated and low dose scans. Both companies are looking
forward to joining forces to drive innovation in medical
imaging.
"We are proud to collaborate with Bayer to combine our expertise
and drive innovative solutions in light of the ever increasing
demands of medical imaging," said Dr Ajit
Shankaranarayanan, Chief Product Officer at Subtle Medical.
"At Subtle Medical, we are committed to continued innovation and
the development of AI tools that create a meaningful impact for
both radiologists and patients."
Subtle Medical's clinically validated AI-powered software
solutions increase the efficiency of image capture by improving the
quality of accelerated and low dose imaging. Subtle's solutions are
compatible with all scanner brands, models and field strengths so
institutions can see the benefit across their entire scanner
fleet. Meet with Subtle Medical at RSNA 2021.
"Bayer is a key partner due to their clinical expertise and
proven track record in medical imaging. Such collaborations across
the industry will be crucial to unlock the power of AI, ultimately
benefiting patients, improving imaging capabilities and patient
diagnosis worldwide," said Josh
Gurewitz, Chief Commercial Officer at Subtle Medical.
About Subtle Medical
Subtle Medical is a global
healthcare technology company with a suite of deep learning
solutions, including SubtlePET™ and SubtleMR™, that increase the
quality and efficiency of medical imaging. Subtle's deep learning
solutions are deployed in top academic hospitals and leading
imaging institutions worldwide. It was named CB Insights Top AI 100
and Digital Health 150 company in 2020 and is an Nvidia Inception
Award Winner. For more information, please visit
subtlemedical.com or email sales@subtlemedical.com.
Media contact:
Anna Menyhart-Borroni
Head of Marketing
+1 501.766.2662
anna@subtlemedical.com
About Bayer
Bayer is a global enterprise with core
competencies in the life science fields of health care and
nutrition. Its products and services are designed to help people
and planet thrive by supporting efforts to master the major
challenges presented by a growing and aging global population.
Bayer is committed to drive sustainable development and generate a
positive impact with its businesses. At the same time, the Group
aims to increase its earning power and create value through
innovation and growth. The Bayer brand stands for trust,
reliability and quality throughout the world. In fiscal 2020, the
Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before
special items amounted to 4.9 billion
euros. For more information, go to www.bayer.com.
Media contact:
Jennifer May
Bayer Communications
+1 412.656.8192
jennifer.may@bayer.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/subtle-medical-and-bayer-collaborate-to-advance-deep-learning-research-to-harness-the-power-of-ai-in-medical-imaging-301432567.html
SOURCE Subtle Medical